Billiontoone, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
BillionToOne, Inc. announced significant revenue growth of 64% year-over-year for Q2 2026, driven by increased test volumes and higher average selling prices, alongside a substantial increase in cash and cash equivalents.
NASDAQ
BillionToOne, Inc. announces significant revenue and profit increase in Q1 2026, driven by strong test volume and ASP growth in prenatal and oncology diagnostics.